Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Night-time Ketamine Infusion for Cancer Bone Metastasis Pain
TCTR20241105002Phase 4Unknown
- Sponsor
- Chulalongkorn University
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketamine in cancer pain and bone metastases (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Analgesic efficacy. Status: unknown.
02
Drugs
ketamine
03
Conditions
cancer painbone metastases
Beyond the preview
Go deeper on TCTR20241105002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241105002.